1. Home
  2. HAFC vs CDNA Comparison

HAFC vs CDNA Comparison

Compare HAFC & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanmi Financial Corporation

HAFC

Hanmi Financial Corporation

HOLD

Current Price

$29.02

Market Cap

758.9M

Sector

Finance

ML Signal

HOLD

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.87

Market Cap

712.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HAFC
CDNA
Founded
1982
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
758.9M
712.2M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
HAFC
CDNA
Price
$29.02
$19.87
Analyst Decision
Hold
Buy
Analyst Count
3
7
Target Price
$28.50
$26.00
AVG Volume (30 Days)
190.5K
816.3K
Earning Date
01-27-2026
11-04-2025
Dividend Yield
3.72%
N/A
EPS Growth
15.36
N/A
EPS
2.40
1.22
Revenue
$246,352,000.00
$357,998,000.00
Revenue This Year
$19.61
$14.11
Revenue Next Year
$11.05
$12.00
P/E Ratio
$12.10
$16.92
Revenue Growth
5.84
14.46
52 Week Low
$19.25
$10.96
52 Week High
$29.28
$25.95

Technical Indicators

Market Signals
Indicator
HAFC
CDNA
Relative Strength Index (RSI) 69.38 66.31
Support Level $28.81 $18.36
Resistance Level $29.28 $19.95
Average True Range (ATR) 0.55 0.87
MACD 0.07 0.16
Stochastic Oscillator 77.72 75.59

Price Performance

Historical Comparison
HAFC
CDNA

About HAFC Hanmi Financial Corporation

Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

Share on Social Networks: